Discontinued — last reported Q3 '25
GE HealthCare Technologies Intangibles (Net) increased by 68.8% to $1.91B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 54.1%, from $1.24B to $1.91B. Over 3 years (FY 2022 to FY 2025), Intangibles (Net) shows a downward trend with a -9.4% CAGR.
High levels reflect significant investment in growth through acquisitions; changes indicate the impact of amortization or impairment charges.
This includes the value of acquired intellectual property, such as patents, trademarks, and drug licenses, net of accumu...
Very high in the pharmaceutical industry due to the reliance on patent-protected drug portfolios.
intangible_assets_net| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.52B | $1.49B | $1.42B | $1.33B | $1.25B | $1.17B | $1.20B | $1.13B | $1.08B | $1.24B | $1.22B | $1.16B | $1.13B | $1.91B |
| QoQ Change | — | -1.7% | -4.8% | -6.4% | -5.9% | -6.3% | +1.8% | -5.3% | -4.8% | +14.8% | -1.5% | -4.7% | -2.8% | +68.8% |
| YoY Change | — | — | — | — | -17.6% | -21.4% | -16.0% | -15.0% | -14.0% | +5.5% | +2.1% | +2.7% | +4.8% | +54.1% |